All In Biotech

NDA 019522 · Allegiance Hlthcare

Povidone Iodine

Povidone-Iodine · Topical

Last checked: Nov 20, 2026Latest source record: Mar 31, 1989 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1989

Mar 31, 1989

Approved uses

1

Original approval plus efficacy supplements

Registered trials

262

51 Phase 3, 12 recruiting

FAERS reports

2,059

1,932 serious, 361 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Mar 31, 1989 Original approval · Type 3 - New Dosage Form
1 products under this application
  • POVIDONE IODINE · POVIDONE-IODINE 1% · SOLUTION, TOPICAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Povidone-Iodine" as an intervention, any sponsor and status, largest first.

All 262 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • off label use320
  • endophthalmitis229
  • drug ineffective191
  • nausea191
  • rash187
  • pain176
  • drug hypersensitivity166
  • product use in unapproved indication144
  • confusional state142
  • rheumatoid arthritis142
  • pericarditis137
  • wound135

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200455
200527
200635
200751
200859
200953
201059
201173
201285
201349
201453
201541
201666
2017120
2018109
2019193
2020104
202155
2022169
2023106
2024142
2025216
2026139

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 902 on PubMed

Sponsor: Allegiance Hlthcare

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.